Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Long-term survival after resection of small hepatocellular carcinoma in patients with preserved liver function

Primary resection and salvage transplantation may be a feasible and rational strategy for patients with small HCC and preserved liver function according to a report in the latest issue of Annals of Surgery.

News image

fiogf49gjkf04

Primary resection, followed by transplantation for recurrence or deterioration of liver function, has recently been suggested as a rational strategy for patients with preserved liver function and hepatocellular carcinomas (HCC) 5 cm or smaller.

However, there are no published data on transplantability after HCC recurrence, or on long-term deterioration of liver function after resection of small HCC in Child-Pugh class A patients. Such data are critical in determining the feasibility of salvage transplantation.

Writing in the March issue of the journal, scientists from the Center for the Study of Liver Disease and Department of Surgery at the University of Hong Kong Medical Center, Hong Kong, China, describe the efforts they took to try and rectify this lack of data.

The research group evaluated the survival results and pattern of recurrence after resection of potentially transplantable small HCC in patients with preserved liver function, with special reference to the implications for a strategy of salvage transplantation.

Using a prospective database, the team examined information on a total of 473 patients who had undergone resection of HCC between 1989 and 1999.

Within the study group, 135 patients aged 65 years or younger, had Child-Pugh class A chronic liver disease (chronic hepatitis or cirrhosis) and transplantable small HCC (solitary 5 cm or two or three tumors 3 cm).

Survival results were analyzed, and the pattern of recurrence was examined for eligibility for salvage transplantation, based on the same criteria as those of primary transplantation for HCC.

Overall survival rates at 1, 3, 5, and 10 years were 90%, 76%, 70%, and 35%, respectively.

The corresponding disease-free survival rates were 74%, 50%, 36%, and 22%.

Cirrhosis and oligonodular tumors were predictive of worse disease-free survival.

Patients with concomitant oligonodular tumors and cirrhosis had a 5-year overall survival rate of 48%, and a disease-free survival rate of 0%, which were significantly worse compared with other subgroups.

Strategy for small HCC with good liver function: resection and later salvage transplantation
Annals of Surgery

At a median follow-up of 48 months, 67 patients had recurrence and 53 (79%) of them were considered eligible for salvage transplantation.

Decompensation from Child-Pugh class A to B or C without recurrence occurred in only 6 patients.

Dr Ronnie Tung-Ping Poon, speaking on behalf of the research group commented "For Child-Pugh class A patients with small HCC, hepatic resection is a reasonable first-line treatment, and is associated with a favorable 5-year overall survival rate."

He continued, "A considerable proportion of patients may survive without recurrence for 5 or even 10 years, and among those with recurrence, the majority may be eligible for salvage transplantation."

"These data suggest that primary resection and salvage transplantation may be a feasible and rational strategy for patients with small HCC and preserved liver function."

"However, primary transplantation may be a preferable option for the subset of patients with oligonodular tumors in cirrhotic liver, in view of the poor survival results after resection", he concluded.

Ann Surg 2002; 235(3): 373-382
11 March 2002

Go to top of page Email this page Email this page to a colleague

 19 January 2018 
Ileoanal pouch microbiota
 19 January 2018 
Predicting the risk of early surgery in Crohn’s
 19 January 2018 
Lifestyle intervention vs gastric bypass for obesity and diabetes
 18 January 2018 
Sleeve gastrectomy vs Roux-en-Y gastric bypass
 18 January 2018 
Healthcare costs of liver cancer in the USA
 18 January 2018 
High-risk adenomas at colonoscopy
 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Management of abnormal liver blood tests
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us